Home / Companies / Omega Therapeutics Inc / Roles
Omega Therapeutics Inc H-1B role rows
Row-level LCA role declarations for Omega Therapeutics Inc, including title, SOC code, worksite, status, date fields, wage offer, prevailing wage, and source record evidence. Showing 18 returned rows using keyset pagination.
Summary
This view lists 18 H-1B LCA role records.
Offered wages among the returned rows range from $65,000 to $220,000.
Employers in the returned rows include Omega Therapeutics, Inc..
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Role | Employer | SOC | Status / visa | Decision | Worksite | Offered wage | Prevailing wage | Source |
|---|---|---|---|---|---|---|---|---|
| Associate Director I-200-24060-758436 | Omega Therapeutics, Inc. | 19-1029.01 Bioinformatics Scientists | Certified / H-1B FY2024 | 2024-03-07 2024-03-11 to 2027-03-10 | Cambridge, MA, 02141 | $180,200 year | $131,123 | sr_dol_oflc_lca_2024_q2_row_038588 |
| Senior Research Associate I-200-22089-021703 | Omega Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | Certified - Withdrawn / H-1B FY2024 | 2024-02-23 2022-09-29 to 2025-09-28 | Cambridge, MA, 02140 | $85,000 year | $84,448 | sr_dol_oflc_lca_2024_q2_row_060345 |
| Associate Director, CMC Project Management I-200-23242-309010 | Omega Therapeutics, Inc. | 13-1041.07 Regulatory Affairs Specialists | Certified / H-1B FY2023 | 2023-09-07 2023-09-01 to 2026-08-31 | Cambridge, MA, 02141 | $162,000 year | $104,957 | sr_dol_oflc_lca_2023_q4_row_040179 |
| Scientist I-200-23215-235857 | Omega Therapeutics, Inc. | 19-2032.00 Materials Scientists | Certified / H-1B FY2023 | 2023-08-10 2023-10-01 to 2026-09-30 | Cambridge, MA, 02141 | $120,000 year | $105,539 | sr_dol_oflc_lca_2023_q4_row_081306 |
| Scientist I-200-23215-235624 | Omega Therapeutics, Inc. | 19-2032.00 Materials Scientists | Withdrawn / H-1B FY2023 | 2023-08-03 2023-10-01 to 2026-09-30 | Cambridge, MA, 02141 | $120,000 year | $105,539 | sr_dol_oflc_lca_2023_q4_row_089031 |
| Senior Research Associate I-200-23088-888021 | Omega Therapeutics, Inc. | 19-1042.00 Medical Scientists, Except Epidemiologists | Certified / H-1B FY2023 | 2023-04-05 2023-09-28 to 2026-09-27 | Cambridge, MA, 02140 | $77,625 year | $61,589 | sr_dol_oflc_lca_2023_q3_row_180534 |
| Research Associate I-200-23088-887011 | Omega Therapeutics, Inc. | 19-1042.00 Medical Scientists, Except Epidemiologists | Certified / H-1B FY2023 | 2023-04-05 2023-09-28 to 2026-09-27 | Cambridge, MA, 02140 | $77,625 year | $61,589 | sr_dol_oflc_lca_2023_q3_row_180728 |
| Research Associate I-200-23088-887047 | Omega Therapeutics, Inc. | 19-1042.00 Medical Scientists, Except Epidemiologists | Certified / H-1B FY2023 | 2023-04-05 2023-09-28 to 2026-09-27 | Cambridge, MA, 02140 | $77,625 year | $61,589 | sr_dol_oflc_lca_2023_q3_row_180803 |
| Data Engineer I-200-23088-887039 | Omega Therapeutics, Inc. | 15-2051.00 Data Scientists | Certified / H-1B FY2023 | 2023-04-05 2023-09-28 to 2026-09-27 | Cambridge, MA, 02140 | $103,500 year | $85,280 | sr_dol_oflc_lca_2023_q3_row_180908 |
| Senior Director, Safety & Pharmacovigilance I-200-23032-743140 | Omega Therapeutics, Inc. | 11-9199.01 Regulatory Affairs Managers | Certified / H-1B FY2023 | 2023-02-08 2023-02-06 to 2026-02-05 | Cambridge, MA, 02140 | $215,000 year | $180,294 | sr_dol_oflc_lca_2023_q2_row_090520 |
| Research Associate I-200-22089-021692 | Omega Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | Certified / H-1B FY2022 | 2022-04-06 2022-09-29 to 2025-09-28 | Cambridge, MA, 2140 | $80,000 year | $58,677 | sr_dol_oflc_lca_2022_q3_row_008457 |
| Senior Research Associate I-200-22089-021703 | Omega Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | Certified / H-1B FY2022 | 2022-04-06 2022-09-29 to 2025-09-28 | Cambridge, MA, 2140 | $85,000 year | $84,448 | sr_dol_oflc_lca_2022_q3_row_009386 |
| Associate Director, Regulatory I-200-22069-969610 | Omega Therapeutics, Inc. | 11-9199.01 Regulatory Affairs Managers | Certified / H-1B FY2022 | 2022-03-17 2022-03-21 to 2025-03-20 | Cambridge, MA, 2140 | $220,000 year | $168,210 | sr_dol_oflc_lca_2022_q2_row_122115 |
| Associate Director, Business Development I-200-22069-969615 | Omega Therapeutics, Inc. | 11-2021.00 Marketing Managers | Certified / H-1B FY2022 | 2022-03-17 2022-03-21 to 2025-03-20 | Cambridge, MA, 2140 | $175,000 year | $154,960 | sr_dol_oflc_lca_2022_q2_row_122369 |
| Senior Scientist, Genomics I-200-21145-341603 | Omega Therapeutics, Inc. | 19-1029.01 Bioinformatics Scientists | Certified / H-1B FY2021 | 2021-06-02 2021-10-01 to 2024-09-30 | Cambridge, MA, 2140 | $130,000 year | $121,098 | sr_dol_oflc_lca_2021_q3_row_342547 |
| Senior CMC Project Manager I-200-21063-120068 | Omega Therapeutics, Inc. | 13-1041.07 Regulatory Affairs Specialists | Certified / H-1B FY2021 | 2021-03-11 2021-03-22 to 2024-03-21 | Cambridge, MA, 02140 | $125,000 year | $100,880 | sr_dol_oflc_lca_2021_q2_row_038102 |
| Senior CMC Project Manager I-200-21063-120068 | Omega Therapeutics, Inc. | 13-1041.07 Regulatory Affairs Specialists | Certified / H-1B FY2021 | 2021-03-11 2021-03-22 to 2024-03-21 | Cambridge, MA, 2140 | $125,000 year | $100,880 | sr_dol_oflc_lca_2021_q3_row_171755 |
| Research Associate I-200-20055-344621 | Omega Therapeutics, Inc. | 19-4021.00 Biological Technicians | Certified / H-1B FY2020 | 2020-03-02 2020-08-21 to 2023-08-20 | Cambridge, MA, 2139 | $65,000 year | $63,357 | sr_dol_oflc_lca_2020_q2_row_087070 |
End of returned pageReset
Frequently asked questions
- What are the offered H-1B wages for Omega Therapeutics Inc H-1B role rows?
- Offered wages among the returned Omega Therapeutics Inc H-1B role rows rows range from $65,000 to $220,000 in DOL LCA filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/roles?limit=50&company=omega+therapeutics+incJSON